Ischemia-reperfusion (I/R) injury, uncommon among patients suffering from myocardial infarction, stroke, or acute kidney injury, can result in cell death and organ dysfunction. Previous studies have shown that different types of cell death, including apoptosis, necrosis, and autophagy, can occur during I/R injury. Pyroptosis, which is characterized by cell membrane pore formation, pro-inflammatory cytokine release, and cell burst, and which differentiates itself from apoptosis and necroptosis, has been found to be closely related to I/R injury. Therefore, targeting the signaling pathways and key regulators of pyroptosis may be favorable for the treatment of I/R injury, which is far from adequate at present. This review summarizes the current status of pyroptosis and its connection to I/R in different organs, as well as potential treatment strategies targeting it to combat I/R injury.
Keyphrases
- cell death
- oxidative stress
- cell cycle arrest
- acute kidney injury
- nlrp inflammasome
- ischemia reperfusion injury
- endoplasmic reticulum stress
- signaling pathway
- current status
- heart failure
- stem cells
- atrial fibrillation
- cancer therapy
- cell therapy
- induced apoptosis
- drug delivery
- combination therapy
- subarachnoid hemorrhage